By Sheeba M. | May 31, 2026
Cannabis Credit Markets Are Thawing: What Falling Debt Costs Mean for Your Stocks
The cannabis credit market is experiencing a dramatic thaw, and it’s the clearest proof yet that institutional capital is returning to the sector with conviction.
Historically, cannabis operators paid 10-14% interest rates on mezzanine and senior secured debt. Today, lenders are offering 6-8% rates, with a handful of players accessing capital at under 7%—a level that seemed impossible just 18 months ago. What’s driving the shift? Three things: (1) federal rescheduling momentum has de-risked the regulatory timeline, (2) the MSO sector is now generating positive EBITDA, and (3) debt investors have moved from fear to greed.
The Math on Margin Relief
For a $1.5B enterprise like Curaleaf (CURLF), a 300-basis-point decline in borrowing costs translates to roughly $45M in annual interest savings. That’s not chump change. On $1B in revenue with 20% EBITDA margins, that $45M flows straight to the bottom line—a 22.5% margin uplift in interest expense, which mathematically means 2-3% accretion to overall net income.
Green Thumb Industries (GTBIF) and Cresco Labs (CRLBF) are refinancing their debt ladders too. Verano Holdings (VRNO) is locking in 7.5% rates on its most recent mezzanine round—a signal that mid-cap operators with proven cash flow are now competitive with traditional consumer retail on borrowing costs.
Why This Matters More Than It Looks
The credit market is usually the first domino to fall in sector recovery. Banks don’t lend to industries they think will fail. When debt costs plummet, it’s because lenders have reset their risk models. They’re saying: “We think these companies will exist in 5 years, and we’re willing to take 7-8% returns to be part of that growth.”
That’s institutional capital talking. And institutional capital flows to fundamentals, not sentiment.
What’s Next?
Watch for two catalysts in June-July:
1. Refinancing Announcements – Large operators will likely announce debt refinancing deals at these new rates. Each announcement will be 2-3% accretive to EPS and could spark rally days in the sector.
2. Capital Deployment – With cheaper debt available, some operators will pivot from debt paydown to M&A and expansion capex. That signals confidence in terminal market valuations and could accelerate consolidation.
Trulieve Cannabis (TCNNF) has the debt capacity to deploy another $200M+ if management believes acquisition targets are fairly valued. Don’t be surprised if that happens by Q3.
Sources
- Reuters — Cannabis debt financing trends
- Bloomberg — Mezzanine debt pricing data
- SEC EDGAR — MSO debt filings
Track cannabis stocks with the Weedstock Real-Time Tracker